Oscar Health (NYSE:OSCR) Reaches New 1-Year High - Still a Buy?

Key Points

• Oscar Health's stock reached a new 52-week high of $23.41, closing slightly lower at $23.30, with a trading volume of 954,723 shares.
• Despite the stock's recent performance, analysts remain cautious, with an average rating of "Strong Sell" and a consensus target price of $12.64.
• The company reported a 29% year-over-year revenue increase, though it still posted a loss of ($0.89) earnings per share, beating analyst expectations by one cent.

Oscar Health, Inc. (NYSE:OSCR - Get Free Report) hit a new 52-week high on Tuesday . The stock traded as high as $23.41 and last traded at $23.30, with a volume of 954723 shares traded. The stock had previously closed at $22.31.

Analyst Ratings Changes

Several research firms have recently issued reports on OSCR. Weiss Ratings reaffirmed a "sell (d)" rating on shares of Oscar Health in a research note on Saturday, September 27th. Piper Sandler lowered their price target on Oscar Health from $14.00 to $13.00 and set a "neutral" rating for the company in a research report on Thursday, August 14th. UBS Group reiterated a "sell" rating and set a $11.00 price objective (down previously from $15.00) on shares of Oscar Health in a research report on Tuesday, July 15th. Raymond James Financial lowered shares of Oscar Health from an "outperform" rating to a "market perform" rating in a report on Tuesday, June 24th. Finally, Wells Fargo & Company lifted their price target on shares of Oscar Health from $10.00 to $14.00 and gave the stock an "underweight" rating in a research note on Tuesday. Four research analysts have rated the stock with a Hold rating and six have given a Sell rating to the stock. According to MarketBeat.com, Oscar Health currently has an average rating of "Strong Sell" and a consensus target price of $12.64.

Oscar Health Stock Up 3.9%

The stock has a market cap of $5.99 billion, a PE ratio of -29.01 and a beta of 1.89. The business has a fifty day moving average of $17.21 and a 200-day moving average of $15.68. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.86 and a quick ratio of 0.86.

Oscar Health (NYSE:OSCR - Get Free Report) last issued its earnings results on Wednesday, August 6th. The company reported ($0.89) earnings per share for the quarter, beating analysts' consensus estimates of ($0.90) by $0.01. Oscar Health had a negative return on equity of 13.78% and a negative net margin of 1.50%.The business had revenue of $2.86 billion during the quarter, compared to analyst estimates of $2.88 billion. During the same period in the previous year, the company posted $0.20 EPS. Oscar Health's revenue was up 29.0% on a year-over-year basis. Equities research analysts anticipate that Oscar Health, Inc. will post 0.69 earnings per share for the current year.

Insider Buying and Selling at Oscar Health

In related news, insider Mario Schlosser sold 395,000 shares of the firm's stock in a transaction dated Monday, September 22nd. The stock was sold at an average price of $18.43, for a total transaction of $7,279,850.00. Following the sale, the insider owned 501,148 shares of the company's stock, valued at $9,236,157.64. This trade represents a 44.08% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 25.11% of the stock is owned by company insiders.

Institutional Trading of Oscar Health

Several hedge funds have recently modified their holdings of OSCR. Hsbc Holdings PLC boosted its position in shares of Oscar Health by 2.7% in the 1st quarter. Hsbc Holdings PLC now owns 24,113 shares of the company's stock worth $313,000 after purchasing an additional 632 shares in the last quarter. Straightline Group LLC increased its holdings in shares of Oscar Health by 3.7% during the second quarter. Straightline Group LLC now owns 18,082 shares of the company's stock valued at $388,000 after acquiring an additional 640 shares in the last quarter. Wealthspire Advisors LLC raised its position in shares of Oscar Health by 6.7% in the 2nd quarter. Wealthspire Advisors LLC now owns 11,117 shares of the company's stock valued at $238,000 after purchasing an additional 700 shares during the last quarter. PNC Financial Services Group Inc. lifted its stake in shares of Oscar Health by 14.4% during the second quarter. PNC Financial Services Group Inc. now owns 7,140 shares of the company's stock worth $153,000 after buying an additional 900 shares during the period. Finally, Tempus Wealth Planning LLC grew its holdings in shares of Oscar Health by 6.7% during the first quarter. Tempus Wealth Planning LLC now owns 14,392 shares of the company's stock valued at $189,000 after buying an additional 906 shares during the last quarter. 75.70% of the stock is owned by hedge funds and other institutional investors.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.